Results 221 to 230 of about 44,225 (262)
Some of the next articles are maybe not open access.
The new microbiologica, 2006
Linezolid, an oxazolidinone that acts by inhibiting protein synthesis, was evaluated in strains of tuberculosis and non-tubercular mycobacteria resistant to one or more drugs isolated in northern Sardinia. The in vitro activity of Linezolid (Pfizer) was assessed on different isolates of Mycobacterium spp.
MOLICOTTI, Paola +5 more
openaire +2 more sources
Linezolid, an oxazolidinone that acts by inhibiting protein synthesis, was evaluated in strains of tuberculosis and non-tubercular mycobacteria resistant to one or more drugs isolated in northern Sardinia. The in vitro activity of Linezolid (Pfizer) was assessed on different isolates of Mycobacterium spp.
MOLICOTTI, Paola +5 more
openaire +2 more sources
[Mycobacteria other than tuberculosis combined primary lung cancer].
Kyobu geka. The Japanese journal of thoracic surgery, 2004From January 1997 to June 1999, we performed surgery in 17 patients with mycobacteria other than tuberculosis (MOTT), and 2 patients with lung cancer among them. Both patients had the diagnosis of MOTT by sputa bacterial cultures preoperatively, but no diagnosis of lung cancer.
Y, Tsunezuka +5 more
openaire +1 more source
Molecular surveillance of tuberculosis-causing mycobacteria in wastewater
Heliyon, 2022Hlengiwe N Mtetwa +2 more
exaly
DRUG-RESISTANCE IN M. TUBERCULOSIS AND OTHER MYCOBACTERIA
Clinics in Chest Medicine, 1980openaire +2 more sources
MEDICAL MANAGEMENT OF MYCOBACTERIA OTHER THAN TUBERCULOSIS
Chest Surgery Clinics of North America, 1993Artin Mahmoudi, Michael D. Iseman
openaire +1 more source
Metabolism in Mycobacterium leprae, M. tuberculosis and other pathogenic mycobacteria
British Medical Bulletin, 1988P R, Wheeler, C, Ratledge
openaire +2 more sources